The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history
Open accessAbstract
PurposePanel-based genetic testing has identified increasing numbers of patients with pancreatic ductal adenocarcinoma (PDAC) who carry germ-line mutations. However, small sample sizes or number of genes evaluated limit prevalence estimates of these mutations. We estimated prevalence of mutations in PDAC patients with positive family history.MethodsWe sequenced 25 cancer susceptibility genes in lymphocyte DNA from 302 PDAC patients in the Mayo Clinic Biospecimen Resource for Pancreatic Research Registry. Kindreds containing at least two first-degree relatives with PDAC met criteria for familial pancreatic cancer (FPC), while the remaining were familial, but not FPC.ResultsThirty-six patients (12%) carried at least one deleterious mutation in one of 11 genes. Of FPC patients, 25/185 (14%) were carriers, while 11/117 (9%) non-FPC patients with family history were carriers. Deleterious mutations (n) identified in PDAC patients were BRCA2 (11), ATM (8), CDKN2A (4), CHEK2 (4), MUTYH/MYH (3 heterozygotes, not biallelic), BRCA1 (2), and 1 each in BARD1, MSH2, NBN, PALB2, and PMS2. Novel mutations were found in ATM, BARD1, and PMS2.ConclusionMultiple susceptibility gene testing in PDAC patients with family history of pancreatic cancer is warranted regardless of FPC status and will inform genetic risk counseling for families.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deleterious variants in the known pancreatic cancer susceptibility genes account for ~10–20% of the familial clustering of pancreatic cancer.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662
Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors
Tassan, N. A. A., Chmiel, N. H., Maynard, J. H., Fleming, N. I., Livingston, A. L., Williams, G. T., Hodges, A., Davies, D. R., David, S. S., Sampson, J. R., et al. (2002) · Nature Genetics · doi:10.1038/ng828 · Cited by 1,408
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826 · cited 13×
“Twenty-seven individuals were found to carry a PV in a gene associated with increased risk of breast cancer (ATM, BARD1, BRCA1, BRCA2, CHEK2, PALB2, NBN).”
InfluentialLocalization of an ataxia-telangiectasia gene to chromosome 11q22–23
Gatti, R. A., Berkel, İ., Boder, E., Braedt, G., Charmley, P., CONCANNON, P. J., Ersoy, F., Foroud, T., Jaspers, N. G. J., Lange, K. L., et al. (1988) · Nature · doi:10.1038/336577a0 · Cited by 684
Genetic/Familial High-Risk Assessment: Breast and Ovarian
Daly, M. B., Axilbund, J. E., Buys, S. S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0043 · Cited by 646
Tung, N., Lin, N., Kidd, J., Allen, B. A., Singh, N., WENSTRUP, R. J., Hartman, A., Winer, E. P., & Garber, J. E. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.0747 · Cited by 580
Self-citationCHEK2 Is a Multiorgan Cancer Susceptibility Gene
Cybulski, C., Górski, B., Huzarski, T., Masojć, B., Mierzejewski, M., Dębniak, T., Teodorczyk, U., Byrski, T., Gronwald, J., Matyjasik, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/426403 · Cited by 560
Risk of Pancreatic Cancer in Families With Lynch Syndrome
Kastrinos, F. (2009) · JAMA · doi:10.1001/jama.2009.1529 · Cited by 544
Cited by
Sorted by citations
Daly, M. B., Pal, T., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A. M., Friedman, S., Goggins, M., Hutton, M. L., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0001 · Cited by 1,143
Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659
Hu, C., Hart, S. N., Polley, E. C., Gnanaolivu, R., Shimelis, H., Lee, K. Y., Lilyquist, J., Na, J., Moore, R., Antwi, S. O., et al. (2018) · JAMA · doi:10.1001/jama.2018.6228 · Cited by 577
Self-citationPancreatic cancer: A review of epidemiology, trend, and risk factors
Hu, J.-X., Zhao, C., Chen, W.-B., Liu, Q., Li, Q.-W., Lin, Y., & Gao, F. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i27.4298 · Cited by 643
Daly, M. B., Pilarski, R., Yurgelun, M. B. B., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A. M., Friedman, S., Garber, J. E., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0017 · Cited by 517
Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine
Aguirre, A. J., Nowak, J. A., Camarda, N. D., Moffitt, R. A., Ghazani, A. A., Hazar-Rethinam, M., Raghavan, S., Kim, J., Brais, L. K., Ragon, D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0275 · Cited by 367
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
Zhu, H., Wei, M., Xu, J., Hua, J., Chen, L., Meng, Q., Zhang, Y., Liu, J., Zhang, B., Yu, X., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01167-9 · Cited by 263
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
Lowery, M. A., Wong, W., Jordan, E. J., Lee, J. W., Kemel, Y., Vijai, J., Mandelker, D., Zehir, A., Capanu, M., Salo-Mullen, E., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy024 · Cited by 224
Wattenberg, M. M., Asch, D., Yu, S., O'Dwyer, P. J., Domchek, S. M., Nathanson, K. L., Rosen, M. A., Beatty, G. L., Siegelman, E. S., & Reiss, K. A. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0582-7 · Cited by 211
Hall, M. J., Bernhisel, R., Hughes, E., Larson, K., Rosenthal, E. T., Singh, N. A., Lancaster, J. M., & Kurian, A. W. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0448 · Cited by 173
Self-citationEarly-Onset Cancer in the Gastrointestinal Tract Is on the Rise—Evidence and Implications
Ben‐Aharon, I., van Laarhoven, H. W. M., Fontana, E., Obermannova, R. L., Nilsson, M., & Lordick, F. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1038 · Cited by 171
Long-term yield of pancreatic cancer surveillance in high-risk individuals
Overbeek, K. A., Levink, I. J. M., Koopmann, B. D. M., Harinck, F., Konings, I. C. A. W., Ausems, M. G. E. M., Wagner, A., Fockens, P., van Eijck, C. H., Groot Koerkamp, B., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-323611 · Cited by 164
Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer
Tamura, K., Yu, J., Hata, T., Suenaga, M., Shindo, K., Abe, T., MacGregor-Das, A., Borges, M., Wolfgang, C. L., Weiss, M. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720588115 · Cited by 95
Self-citationPeran, I., Madhavan, S., Byers, S. W., & McCoy, M. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0290 · Cited by 96
Hanson, H., Astiazarán-Symonds, E., Amendola, L. M., Balmañà, J., Foulkes, W. D., James, P. A., Klugman, S. D., Ngeow, J. Y. Y., Schmutzler, R. K., Voian, N. C., et al. (2023) · Genetics in Medicine · doi:10.1016/j.gim.2023.100870 · Cited by 94
ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications
Armstrong, S. A., Schultz, C. W., Azimi-Sadjadi, A., Brody, J. R., & Pishvaian, M. J. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0208 · Cited by 77
ATM: Functions of ATM Kinase and Its Relevance to Hereditary Tumors
Ueno, S., Sudo, T., & Hirasawa, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010523 · Cited by 75
Bono, M., Fanale, D., Incorvaia, L., Cancelliere, D., Fiorino, A., Calò, V., Dimino, A., Filorizzo, C., Corsini, L. R., Brando, C., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100235 · Cited by 69
Germline genetic variability in pancreatic cancer risk and prognosis
Gentiluomo, M., Canzian, F., Nicolini, A., Gemignani, F., Landi, S., & Campa, D. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.08.003 · Cited by 68
Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study
Chen, F., Childs, E. J., Mocci, E., Bracci, P. M., Gallinger, S., Li, D., Neale, R. Ε., Olson, S. H., Scélo, G., Bamlet, W. R., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1235 · Cited by 70
Self-citationThe Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer
Kimura, H., Klein, A. P., Hruban, R. H., & Roberts, N. J. (2021) · Pancreas · doi:10.1097/mpa.0000000000001888 · Cited by 65
Rainone, M., Singh, I., Salo‐Mullen, E. E., Stadler, Z. K., & O'Reilly, E. M. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2019.5963 · Cited by 60
Abe, K., Kitago, M., Kitagawa, Y., & Hirasawa, A. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-02015-6 · Cited by 62
Earl, J., Galindo-Pumariño, C., Encinas, J., Barreto, E., Castillo, M. E., Pachón, V., Ferreiro, R., Rodríguez-Garrote, M., González-Martínez, S., y Cajal, T. R., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102675 · Cited by 50
Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers
Alenezi, W. M., Fierheller, C. T., Recio, N., & Tonin, P. N. (2020) · Genes · doi:10.3390/genes11080856 · Cited by 50
Sung, H., Freedman, R. A., Siegel, R. L., Hyun, N., Desantis, C. E., Ruddy, K. J., & Jemal, A. (2021) · Cancer · doi:10.1002/cncr.33602 · Cited by 49
Targeting DNA damage repair pathways in pancreas cancer
Crowley, F., Park, W., & O’Reilly, E. M. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09983-1 · Cited by 43
Chen, F., Roberts, N. J., & Klein, A. P. (2017) · Chinese Clinical Oncology · doi:10.21037/cco.2017.12.04 · Cited by 42
Cremin, C., Lee, M. K. C., Hong, Q., Hoeschen, C., Mackenzie, A., Dixon, K., McCullum, M., Nuk, J., Kalloger, S. E., Karasinska, J. M., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.2973 · Cited by 41
Thompson, E. D., Roberts, N. J., Wood, L. D., Eshleman, J. R., Goggins, M., Kern, S. E., Klein, A. P., & Hruban, R. H. (2020) · Modern Pathology · doi:10.1038/s41379-020-0629-6 · Cited by 41
Informatics strategies for early detection and risk mitigation in pancreatic cancer patients
Jin, D., Khan, N. U., Gu, W., Lei, H., Goel, A., & Chen, T. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101129 · Cited by 35
Yan, J., Yu, S., Jia, C., Li, M., & Chen, J. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188367 · Cited by 33
Astiazarán-Symonds, E., & Goldstein, A. M. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01806-y · Cited by 34
ATM Serine/Threonine Kinase and its Role in Pancreatic Risk
Nanda, N., & Roberts, N. J. (2020) · Genes · doi:10.3390/genes11010108 · Cited by 30
Merkle, J., Breunig, M., Schmid, M., Allgöwer, C., Krüger, J., Melzer, M. K., Bens, S., Siebert, R., Perkhofer, L., Azoitei, N., et al. (2021) · Cancers · doi:10.3390/cancers13205139 · Cited by 27
Seufferlein, T. T. W., Mayerle, J. V., Böck, S., Brunner, T. B., Ettrich, T. J., Grenacher, L., Gress, T. M., Hackert, T., Heinemann, V., Kestler, A. M. R., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1856-7346 · Cited by 29
Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma
Thiruvengadam, S. S., Chuang, J., Huang, R. J., Girotra, M., & Park, W. G. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.08.029 · Cited by 26
Pancreatic Cancer: BRCA Targeted Therapy and Beyond
Keane, F., O'Connor, C. A., Park, W., Seufferlein, T. T. W., & O'Reilly, E. M. (2023) · Cancers · doi:10.3390/cancers15112955 · Cited by 26
Furniss, C. S., Yurgelun, M. B. B., Ukaegbu, C. I., Constantinou, P. E., Lafferty, C. C., Talcove-Berko, E. R., Schwartz, A., Stopfer, J. E., Underhill-Blazey, M. L., Kenner, B. J., et al. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0642 · Cited by 26
Self-citationPaiella, S., Azzolina, D., Gregori, D., Malleo, G., Golan, T., Simeone, D. M., Davis, M., Vacca, P., Crovetto, A., Bassi, C., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.100881 · Cited by 23
Gordon, D. R., Breitkopf, C. R., Robinson, M., Petersen, W. O., Egginton, J. S., Rabe, K. G., Petersen, G. M., Wolf, S. M., & Koenig, B. A. (2018) · AJOB Empirical Bioethics · doi:10.1080/23294515.2018.1546241 · Cited by 24
Self-citationGermline Aberrations in Pancreatic Cancer: Implications for Clinical Care
Casolino, R., Corbo, V., Beer, P. A., Hwang, C., Paiella, S., Silvestri, V., Ottini, L., & Biankin, A. V. (2022) · Cancers · doi:10.3390/cancers14133239 · Cited by 24
Watters, A. K., Seltzer, E. S., MacKenzie, D., Young, M. W., Muratori, J., Hussein, R., Sodoma, A. M., To, J. T., Singh, M., & Zhang, D. (2020) · Genes · doi:10.3390/genes11070829 · Cited by 23
First international workshop of the ATM and cancer risk group (4-5 December 2019)
Lesueur, F., Easton, D. F., Renault, A., Tavtigian, S. V., Bernstein, J. L., Kote‐Jarai, Z., Eeles, R. A., Plaseska-Karanfia, D., Feliubadaló, L., Spanish ATM working group, et al. (2021) · Familial Cancer · doi:10.1007/s10689-021-00248-y · Cited by 21
Katona, B. W., Klute, K. A., Brand, R. E., Everett, J. N., Farrell, J. J., Hawthorne, K. M., Kaul, V., Kupfer, S. S., Paiella, S., Simeone, D. M., et al. (2023) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0529 · Cited by 20
Bennett, C. F., Suguitan, M. D., Abad, J., & Chawla, A. (2022) · Pancreatology · doi:10.1016/j.pan.2022.05.005 · Cited by 18
Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer
Liu, J., Mroczek, M., Mach, A., Stępień, M., Aplas, A., Pronobis‐Szczylik, B., Bukowski, S., Mielczarek, M., Gajewska, E., Topolski, P., et al. (2023) · Cancers · doi:10.3390/cancers15030779 · Cited by 18
Wieme, G., Král, J., Rosseel, T., Zemánková, P., Parton, B., Vočka, M., Heetvelde, M. V., Kleiblová, P., Blaumeiser, B., Soukupová, J., et al. (2021) · Cancers · doi:10.3390/cancers13174430 · Cited by 19
Inherited Pancreatic Cancer Syndromes and High-Risk Screening
Biller, L. H., Wolpin, B. M., & Goggins, M. (2021) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2021.06.002 · Cited by 19
Fountzilas, E., Eliades, A., Koliou, G.-A., Achilleos, A., Loizides, C., Tsangaras, K., Pectasides, D. G., Sgouros, J., Papakostas, P., Rallis, G., et al. (2021) · Cancers · doi:10.3390/cancers13020198 · Cited by 17
Therapeutic Strategies Targeting Tumor Suppressor Genes in Pancreatic Cancer
Kuo, K., Hsiao, P., Chang, W., Chuang, S., Yang, Y.-H., Wuputra, K., Ku, C., Pan, J.-B., Li, C.-P., Kato, K., et al. (2021) · Cancers · doi:10.3390/cancers13153920 · Cited by 17
Powell, C. B., Laurent, C. A., Garcia, C., Hoodfar, E., Karlea, A., Kobelka, C., Lee, J., Roh, J. M., & Kushi, L. H. (2021) · Clinical Genetics · doi:10.1111/cge.14100 · Cited by 17
Expanding cancer predisposition genes with ultra-rare cancer-exclusive human variations
Rasnic, R., Linial, N., & Linial, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-70494-0 · Cited by 17
Frequency and molecular characteristics of PALB2 ‐associated cancers in Russian patients
Преображенская, Е. В., Shleykina, A. Y., Gorustovich, O. A., Martianov, A. S., Валерьевич, Б. И., Anisimova, E. I., Соколова, Т. Н., Chuinyshena, S. A., Kuligina, E. S., Togo, A. V., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33317 · Cited by 17
The role of molecular testing in pancreatic cancer
Zhen, D. B., Safyan, R. A., Konick, E. Q., Nguyen, R., Pritchard, C. C., & Chiorean, E. G. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231171456 · Cited by 16
Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types
Gentles, L., Goranov, B., Matheson, E. C., Herriott, A., Kaufmann, A., Hall, S., Mukhopadhyay, A., Drew, Y., Curtin, N. J., & O'Donnell, R. L. (2019) · Cancers · doi:10.3390/cancers11030354 · Cited by 15
Pancreatic ductal adenocarcinoma in the era of precision medicine
Zheng-Lin, B., & O'Reilly, E. M. (2021) · Seminars in Oncology · doi:10.1053/j.seminoncol.2021.01.005 · Cited by 16
Matiash, K., Lewis, C. S., & Bogdanov, V. Y. (2021) · Cancers · doi:10.3390/cancers13184652 · Cited by 15
Bile Acids in Pancreatic Carcinogenesis
Sharma, B., Twelker, K., Nguyen, C., Ellis, S., Bhatia, N. D., Kuschner, Z. D., Agriantonis, A., Agriantonis, G., Arnold, M., Dave, J., et al. (2024) · Metabolites · doi:10.3390/metabo14070348 · Cited by 15
Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers
Clark, N. M., Roberts, E. A., Fedorenko, C. R., Sun, Q., Dubard-Gault, M. E., Handford, C., Yung, R. L., Cheng, H. H., Sham, J. G., Norquist, B. M., et al. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12755-y · Cited by 16
Buono, A. D., Poliani, L., Greco, L., Bianchi, P. P., Barile, M., Giatti, V., Bonifacio, C., Carrara, S., Malesci, A., & Laghi, L. (2023) · Cancers · doi:10.3390/cancers15061852 · Cited by 17
Pantaleo, A., Forte, G., Fasano, C., Signorile, M. L., Sanese, P., Marco, K. D., Nicola, E. D., Latrofa, M., Grossi, V., Disciglio, V., et al. (2023) · Cancers · doi:10.3390/cancers16010056 · Cited by 15
Horn, I. P., Marks, D. L., Koenig, A. N., Hogenson, T. L., Almada, L. L., Goldstein, L. E., Romecín, P. A., Vera, R. E., Vrabel, A. M., Cui, G., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100634 · Cited by 17
Self-citationBRCA mutations in pancreatic cancer and progress in their targeting
Alkassis, S., Yazdanpanah, O., & Philip, P. A. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1957462 · Cited by 13
Genetic medicine is accelerating in Japan
Hayashi, S., Kubo, M., Kaneshiro, K., Kai, M., Yamada, M., Morisaki, T., Takao, Y., Shimazaki, A., Shikada, S., & Nakamura, M. (2022) · Breast Cancer · doi:10.1007/s12282-022-01342-4 · Cited by 13
Risk Assessment and Genetic Testing for Inherited Gastrointestinal Syndromes.
Stoll, J., & Kupfer, S. S. (2019) · PubMed Central · Cited by 11
Mohamed, G., Munir, M., Rai, A., & Gaddam, S. (2024) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2024.09.006 · Cited by 10
Katona, B. W., Long, J. M., Ahmad, N. A., Attalla, S., Bradbury, A. R., Carpenter, E. L., Clark, D. F., Constantino, G., Das, K. K., Domchek, S. M., et al. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0161 · Cited by 10
Atypical ATMs: Broadening the phenotypic spectrum of ATM-associated hereditary cancer
Borja, N. A., Silva‐Smith, R., Huang, M. S., Parekh, D. J., Sussman, D. A., & Tekin, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1068110 · Cited by 10
Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma
Ryu, K. H., Park, S.-H., Chun, J. W., Cho, E., Choi, J., Lee, D.-E., Shim, H., Kim, Y., Han, S., Park, S., et al. (2023) · Cancer Research and Treatment · doi:10.4143/crt.2023.291 · Cited by 10
Tan, M., Brusgaard, K., Gerdes, A., Mortensen, M. B., Detlefsen, S., de Muckadell, O. B. S., & Jøergensen, M. T. (2021) · Clinical Genetics · doi:10.1111/cge.14038 · Cited by 10
Vasen, H. F. A. (2017) · Familial Cancer · doi:10.1007/s10689-017-0066-y · Cited by 10
Zhu, W., Chen, L., Aphinyanaphongs, Y., Kastrinos, F., Simeone, D. M., Pochapin, M. B., Stender, C., Razavian, N., & Gonda, T. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-89607-8 · Cited by 8
Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer
Selvi, S., Real, C. M., Gentiluomo, M., Balounová, K., Vokacova, K., Čumová, A., Mohleníková-Duchoňová, B., Rizzato, C., Halášová, E., Vodičková, L., et al. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.05.005 · Cited by 7
Murali, K., Dwarte, T. M., Nikfarjam, M., Tucker, K., Vaughan, R., Efthymiou, M., Collins, A., Spigelman, A. D., Salmon, L., Johns, A. L., et al. (2021) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-021-00190-1 · Cited by 8
Risk factors related to age at diagnosis of pancreatic cancer: a retrospective cohort pilot study
Lin, R., Chen, P., Yang, C., Yeh, C., Lin, C., Huang, W., Chung, A., & Lin, J.-T. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02325-7 · Cited by 8
S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1
Seufferlein, T. T. W., Mayerle, J. V., Boeck, S. H., Brunner, T. B., Ettrich, T. J., Grenacher, L., Gress, T. M., Hackert, T., Heinemann, V., Kestler, A. M. R., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2338-3533 · Cited by 7
Zimmermann, M. T., Mathison, A., Stodola, T. J., Evans, D. B., Abrudan, J., Demos, W., Tschannen, M., Aldakkak, M., Geurts, J. L., Lomberk, G. A., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.606820 · Cited by 7
Saldia, A., Olson, S. H., Nunes, P., Liang, X., Samson, M. L., Salo‐Mullen, E. E., Marcell, V. J., Stadler, Z. K., Allen, P. J., Offit, K., et al. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0272 · Cited by 7
Wang, L. L., Domchek, S. M., Kochman, M. L., & Katona, B. W. (2022) · Genes & Cancer · doi:10.18632/genesandcancer.223 · Cited by 7
Kiyozumi, Y., Matsubayashi, H., Todaka, A., Ashida, R., Nishimura, S., Kado, N., Higashigawa, S., Harada, R., Ishihara, E., Horiuchi, Y., et al. (2024) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-024-00283-7 · Cited by 6
Muhammad, N., Sadaqat, R., Naeemi, H., Masood, I., Hassan, U., Ijaz, B., Hanif, F., Syed, A. A., Yusuf, M. A., & Rashid, M. U. (2022) · HPB · doi:10.1016/j.hpb.2022.09.003 · Cited by 6
Systems biology and OMIC data integration to understand gastrointestinal cancers
Bispo, I. M. C., Granger-Neto, H. P., Almeida, P. P., Nishiyama, P. B., & de Freitas, L. M. (2022) · World Journal of Clinical Oncology · doi:10.5306/wjco.v13.i10.762 · Cited by 6
Rapposelli, I. G., Zampiga, V., Cangini, I., Arcangeli, V., Ravegnani, M., Valgiusti, M., Pini, S., Tamberi, S., Bartolini, G., Passardi, A., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08368-5 · Cited by 7
Bilyalov, A. I., Михайловна, Д. А., Nikolaev, S., Vorobyov, N., Abramov, I. S., Pismennaya, E., Terehova, S., Kosilova, Y., Primak, A., Станоевич, У. С., et al. (2023) · Cancers · doi:10.3390/cancers16010085 · Cited by 5
Forte, G., Buonadonna, A. L., Fasano, C., Sanese, P., Cariola, F., Manghisi, A., Guglielmi, A. F., Signorile, M. L., Marco, K. D., Grossi, V., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147939 · Cited by 5
Matsubayashi, H., Kiyozumi, Y., & Ono, H. (2025) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.12112 · Cited by 5
Loveček, M., Janatová, M., Skalický, P., Zemánek, T., Havlík, R., Ehrmann, J., Strouhal, O., Zemankova, P., Lhotová, K., Borecká, M., et al. (2019) · Cancer Management and Research · doi:10.2147/cmar.s185352 · Cited by 5
Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study
Fujitani, H., Eguchi, H., Kochi, Y., Arai, T., Muramatsu, M., & Okazaki, Y. (2023) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000787 · Cited by 5
Boughey, A., Hopley, P., Sarantitis, I., Thomas, P. G., Gubacsi, B., Jevons, K., Crowe, E., Hughes, E., Quinn, I., Royle, L., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-100027 · Cited by 4
Current status and perspectives of genetic testing in gastrointestinal cancer (Review)
Matsuoka, T., & Yashiro, M. (2023) · Oncology Letters · doi:10.3892/ol.2023.14155 · Cited by 4
Precursor lesions in familial and hereditary pancreatic cancer
Pflüger, M. J., Brosens, L. A. A., & Hruban, R. H. (2024) · Familial Cancer · doi:10.1007/s10689-024-00359-2 · Cited by 4
Understanding familial risk of pancreatic ductal adenocarcinoma
Paranal, R. M., Wood, L. D., Klein, A. P., & Roberts, N. J. (2024) · Familial Cancer · doi:10.1007/s10689-024-00383-2 · Cited by 4
Limijadi, E. K. S., Muniroh, M., Prajoko, Y. W., Tjandra, K. C., & Respati, D. R. P. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299276 · Cited by 5
Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study
Tan, M., Brusgaard, K., Gerdes, A., Mortensen, M. B., Detlefsen, S., de Muckadell, O. B. S., & Jøergensen, M. T. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1937697 · Cited by 4
Discovery of BRCA1/BRCA2 founder variants by haplotype analysis
Kwon, W. K., Jang, H.-J., Lee, J. E., Park, Y. H., Ryu, J. M., Yu, J., Jang, J., & Kim, J. (2022) · Cancer Genetics · doi:10.1016/j.cancergen.2022.05.042 · Cited by 4
Somatic loss of ATM is a late event in pancreatic tumorigenesis
Paranal, R. M., Jiang, Z., Hutchings, D., Kryklyva, V., Gauthier, C., Fujikura, K., Nanda, N., Huang, B., Skaro, M. F., Wolfgang, C. L., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6136 · Cited by 6
Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer
Macklin, S., Kasi, P. M., Jackson, J. L., & Hines, S. L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00330 · Cited by 4
Antwi, S. O., Rabe, K. G., Carlson, E. E., Sicotte, H., Bamlet, W. R., Mills, K. C., Konikoff, T. D., Cerhan, J. R., Couch, F. J., Larson, N. B., et al. (2026) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2026.03.043 · Cited by 3
Rodríguez-Olivares, J. L., Kimball, T. N., Jeter, J., de la Mora‐Molina, H., Núñez, I., Weitzel, J. N., & Chávarri-Guerra, Y. (2024) · Pancreatology · doi:10.1016/j.pan.2024.09.018 · Cited by 3
Metadata
- Authors
- Chaffee, K. G., Oberg, A. L., McWilliams, R. R., Majithia, N., Allen, B. A., Kidd, J., Singh, N., Hartman, A.-R., Wenstrup, R. J., & Petersen, G. M.
- Affiliations
- Mayo Clinic (US)
- Myriad Genetics (US)
- Corresponding author
- Petersen, Gloria M.
- ORCID
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 20
- Issue
- 1
- Pages
- 119-127
- ISSN
- 1098-3600 (ISSN-L)
- PMC
- PMC5760284
- OpenAlex
- W2738571634
- Cited by
- 144
- References
- 38
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 15 · 2023: 23 · 2022: 19 · 2021: 34 · 2020: 14 · 2019: 10 · 2018: 9
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CA102701)
- National Cancer Institute (CA102701, R01CA-97075, P50CA102701, R01CA097075)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- pancreatic ductal adenocarcinoma, germline mutations, cancer susceptibility genes, familial pancreatic cancer, family history (medicine), mutation prevalence, BRCA2, ATM, CDKN2A, CHEK2, MUTYH, BARD1, PMS2, novel mutations
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alleles, Carcinoma, Female, Genetic Testing, Genotype, Humans, Male, Middle Aged, Pancreatic Neoplasms, Registries, United States, Prevalence, Germ-Line Mutation, Genetic Predisposition to Disease, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
